Clinical Trial Update: Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports the termination of a study evaluating palonosetron hydrochloride for preventing radiation-induced nausea and vomiting in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Appendiceal Carcinoma
• Colorectal Cancer
• Gallbladder Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Peritoneal Cancer

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anal Cancer, Carcinoma of the Appendix | Phase 2 | Status: TERMINATED | Results posted: 2017-02-01